Pharmacogenetics and personalized treatment of type 2 diabetes

Citations Over TimeTop 13% of 2013 papers

Abstract

Type 2 diabetes mellitus (T2DM) is a worldwide epidemic with considerable health and economic consequences. T2DM patients are often treated with more than one drug, including oral antidiabetic drugs (OAD) and drugs used to treat diabetic complications, such as dyslipidemia and hypertension. If genetic testing could be employed to predict treatment outcome, appropriate measures could be taken to treat T2DM more efficiently. Here we provide a review of pharmacogenetic studies focused on OAD and a role of common drug-metabolizing enzymes (DME) and drug-transporters (DT) variants in therapy outcomes. For example, genetic variations of several membrane transporters, including SLC2A1/2 and SLC47A1/2 genes, are implicated in the highly variable glycemic response to metformin, a first-line drug used to treat newly diagnosed T2DM. Furthermore, cytochrome P450 (CYP) enzymes are implicated in variation of sulphonylurea and meglitinide metabolism. Additional variants related to drug target and diabetes risk genes have been also linked to interindividual differences in the efficacy and toxicity of OAD. Thus, in addition to promoting safe and cost-effective individualized diabetes treatment, pharmacogenomics has a great potential to complement current efforts to optimize treatment of diabetes and lead towards its effective and personalized care.

Related Papers

• → Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes(2012)113 cited
• → Pharmacogenomics: The Right Drug to the Right Person(2009)113 cited
• → Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions(2017)45 cited
• → Pharmacogenomics and Antihypertensive Drugs: A Path toward Personalized Medicine(2007)4 cited
• → 16 INVITED Pharmacogenomics of anticancer drug disposition: we aren't there yet(2008)1 cited